EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Brain Metastasis of Triple‐Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies

Zhenyu Chen iD, Qiang Sun iD

The Breast Journal · 2026-01 · 2026 (1)

DOI: 10.1155/tbj/5914207 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Breast Journal, online erschienen am 08.11.2026. Verfasst von Zhenyu Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, C…. Hauptthemen laut MEDLINE: Brain Neoplasms, Triple Negative Breast Neoplasms. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer (TNBC) is the most aggressive breast cancer subtype, and is characterized by an early metastatic tendency, marked biological heterogeneity, and poor clinical outcomes. Among all distant metastatic sites, the brain represents one of the most devastating locations, as brain metastasis is associated with substantial neurological morbidity, limited therapeutic options, and short survival. TNBC displays a disproportionate propensity for brain metastasis compared with hormone receptor‐positive disease, yet effective systemic treatment remains challenging because of the blood–brain barrier (BBB), the distinct brain tumor microenvironment (TME), and the absence of broadly applicable molecular targets. In this review, we summarize the molecular basis of TNBC brain metastasis with an emphasis on four major aspects: tumor microenvironmental remodeling, BBB interaction, oncogenic signaling pathways, and metabolic reprogramming. We discuss how reactive astrocytes, microglia, inflammatory cytokines, and tumor‐intrinsic programs collectively facilitate brain colonization and therapeutic resistance. In addition, we review current and emerging treatment strategies, including chemotherapy, antibody–drug conjugates, targeted therapy, immunotherapy, and novel drug‐delivery systems. Particular attention is given to the translational gap between preclinical promise and clinical benefit, the frequent exclusion of patients with active brain metastases from clinical trials, and the need for more rigorous intracranial efficacy assessment. A better understanding of the dynamic interaction between TNBC cells and the brain niche may support the development of more effective and biologically informed therapeutic strategies for this high‐risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsTriple Negative Breast NeoplasmsHumansFemaleBlood-Brain BarrierTumor MicroenvironmentAnimalsImmunotherapyAntineoplastic Agents

Stichwörter der Autor:innen

antibody–drug conjugatesblood–brain barrierblood–tumor barrierbrain metastasisbrain tumor microenvironmentimmunotherapysacituzumab govitecantargeted therapytriple-negative breast cancertumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, cacms.ac.cn.

ORCID-Profile: Zhenyu Chen, Qiang Sun

Zitieren

APA

Chen, Z., & Sun, Q. (2026). Brain Metastasis of Triple‐Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies. The Breast Journal, 2026(1). https://doi.org/10.1155/tbj/5914207

Vancouver

Chen Z, Sun Q. Brain Metastasis of Triple‐Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies. The Breast Journal. 2026;2026(1). doi:10.1155/tbj/5914207

BibTeX
@article{Chen2026,
  author = {Chen, Zhenyu and Sun, Qiang},
  title = {Brain Metastasis of Triple‐Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies},
  journal = {The Breast Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tbj/5914207}
}
Kostenlos starten →